André Rezende at @CredicorpGroup shares why knowing how to direct AI effectively will be key to getting the most out of AI agents and reshaping how teams work. Full episode recorded in partnership with @Kyndryl at @Sibos Miami 2026:

Recent Upgrades on CapCut 🌍 Spend less time moving between tools and more time developing your ideas. Xiaoqi Fu, Global Head of CapCut, shares the vision for bringing video, images, AI, filmmaking, and design into one connected creative process, with human imagination and judgment at its center. Watch the highlights from CapCut World LA.

Recently, Ulanqab, a small city on the grasslands of north China's Inner Mongolia Autonomous Region, has attracted the attention of global investors. 📈A #Goldman# Sachs report says that Ulanqab has emerged as one of the largest and fastest-growing #AI# computing clusters in the Asia-Pacific region. #DeepChina# 🧐As of August 2026, the city's operational computing capacity has reached 190,000 petaflops, with intelligent computing accounting for more than 90% of the total. More than 100 data center projects had been signed, and companies such as #Huawei#, #Alibaba#, and #Apple# were expanding their presence in the city, with total investment exceeding 500 billion yuan. 🥰Following a 50-billion-yuan financing round, Chinese AI company DeepSeek also plans to build a gigawatt-scale, hyperscale AI data center in Ulanqab. According to Goldman Sachs, the combined capacity of #data# centers already in operation and those in the planning pipeline in Ulanqab stands at approximately 12.5 GW, more than 10 times the city's operational capacity in 2025. 😆This rapid growth has helped transform the small city, whose economy has long been dominated by agriculture and animal husbandry, into an emerging #technology# hub. Its GDP exceeded 120 billion yuan last year. 📍Ulanqab's emergence as a major computing hub stems from a combination of advantages: low electricity prices, favorable natural cooling conditions, low-latency connectivity to #Beijing#, direct access to green electricity, and its strategic ambition to become a "Token City." Together, these factors are positioning Ulanqab as a strategically important power #hub# in the global race to expand AI computing capacity. #ChineseNation#

Recent incidents reported in Panchkula and Surat have renewed concerns over online gaming addiction among children and its possible link to aggressive behaviour. The cases have also sparked calls for greater parental supervision and awareness of children's gaming habits. @SimranBabbar_05 with more | @kritsween #panchkula# #surat# #pubg#

Recent artificial intelligence related market stumbles have somewhat burst the bubble of infallibility around the sector, Howard Marks, co-chair of Oaktree Capital Management LP, tells Bloomberg TV.

Recent @WHO guidance is helping countries advance the objectives of the Global Breast Cancer Initiative: early detection, timely diagnosis and quality treatment. Integrated cancer services help bring these within reach, wherever people live. Learn more➡️

Recent tail-risk events across the crypto industry over the past year have reinforced the need for better risk segmentation in managed strategies, curated vaults, and yield-bearing stablecoins. Tranching separates risk and yield into two distinct layers: capital that takes the risk is paid more for it, and capital that does not is protected from it. Junior holders earn amplified yield in exchange for absorbing losses first. Senior holders benefit from automatic protection, backed by junior coverage, with no claims to file or manual intervention required. Same underlying asset. Two distinct points on the risk-reward curve. If you’re a curator, vault infrastructure provider, yield-bearing stablecoin issuer, or credit protocol looking to integrate tranching and distribute your strategies to a diverse investor base, let’s talk.

REGENERON $REGN Q3’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $5.1B (Est. $4.54B) 🟢; +36% YoY 🔹 Adj. EPS: $20.07 (Est. $16.24) 🟢; +70% YoY 🔹 Dupixent Global Net Sales: $6.5B; +35% YoY 🔹 EYLEA HD U.S. Net Sales: $699M; +62% YoY FY26 Guide: 🔹 Non-GAAP R&D: $6.05B-$6.15B; from $5.95B-$6.05B 🔹 Non-GAAP SG&A: $2.4B-$2.5B; from $2.5B-$2.6B 🔹 Non-GAAP Gross Margin: 86%; from 84%-85% 🔹 Capital Expenditures: $1.05B-$1.10B; from $1.03B-$1.10B Product Net Sales: 🔹 Dupixent (Global): $6.5B; +35% YoY 🔹 EYLEA HD - U.S.: $699M; +62% YoY 🔹 EYLEA - U.S.: $400M; -41% YoY 🔹 Libtayo - Global: $550M; +51% YoY 🔹 Sanofi Collab. Revenue: $2.72B; +68% YoY Other Q3 Metrics: 🔹 Non-GAAP Gross Margin: 86%; flat YoY 🔹 Non-GAAP ETR: 15%; +190 bps YoY Capital Return: 🔹 Buybacks: $2.3B 🔹 Remaining Authorization: $2.2B 🔹 Dividend: $0.94/share Key Updates: 🔹 Sanofi Collaboration: $1.0B up-front; up to $7.0B in future milestones 🔹 Pasatru: FDA approved for FOP Comments: 🔸 “This was an outstanding quarter for Regeneron, with Dupixent, EYLEA HD, and Libtayo each achieving record net sales” 🔸 “Finally, we expanded our alliance with Sanofi to include four Regeneron-invented, next-generation, long-acting antibodies designed to build on the success of Dupixent.”